StimLabs Secures First 510(k) for Birth Tissue Wound Care Solution
Placental tissue allograft start-up StimLabs gains market clearance for Corplex P, a particulate product well-suited for wounds with irregular geometry.
MedTech Strategist, the global medical device industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today
Browse Latest IssuePlacental tissue allograft start-up StimLabs gains market clearance for Corplex P, a particulate product well-suited for wounds with irregular geometry.
A blood analysis start-up seeks to provide clinicians with an objective reference where it matters most.
Israeli start-up Magenta Medical progresses toward challenging the pLVAD status quo with an early feasibility study of its Elevate device.